HC Wainwright Reiterates “Buy” Rating for Sensei Biotherapeutics (NASDAQ:SNSE)
HC Wainwright restated their buy rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $4.00 price objective on the stock. Sensei Biotherapeutics Trading Up 18.0 % SNSE opened at $0.51 on Friday. Sensei Biotherapeutics has a 12-month low of […]
HC Wainwright restated their buy rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $4.00 price objective on the stock. Sensei Biotherapeutics Trading Up 18.0 % SNSE opened at $0.51 on Friday. Sensei Biotherapeutics has a 12-month low of […]
